Group 1 - PENN Entertainment is expected to report a year-over-year increase in earnings, with a projected quarterly loss of $0.04 per share, reflecting a change of +77.8% [3][12] - Revenues for PENN are anticipated to be $1.73 billion, which is a 4.3% increase from the same quarter last year [3] - The consensus EPS estimate has been revised 8.61% lower over the last 30 days, indicating a reassessment by analysts [4] Group 2 - The Zacks Earnings ESP for PENN is +23.32%, suggesting a bullish outlook from analysts regarding the company's earnings prospects [12] - The stock currently holds a Zacks Rank of 3, indicating a hold position [12] - Historically, PENN has beaten consensus EPS estimates three out of the last four quarters, with a recent surprise of +13.79% [13][14] Group 3 - Super Group (SGHC) Limited, another player in the gaming industry, is expected to report earnings per share of $0.13, representing a year-over-year change of +62.5% [18] - Revenues for Super Group are projected to be $503 million, up 12.7% from the previous year [18] - The consensus EPS estimate for Super Group has been revised 16.7% lower over the last 30 days, with an Earnings ESP of 0% [19]

The market expects Progyny (PGNY) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates. The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on A ...

Company Overview - Sempra (SRE) is anticipated to report a year-over-year decline in earnings, with expected earnings of $0.83 per share, reflecting a decrease of 6.7% compared to the previous year [3][12] - The company's revenues are projected to be $3.15 billion, which represents an increase of 4.7% from the same quarter last year [3] Earnings Expectations - The earnings report is scheduled for release on August 7, and the actual results will significantly influence the stock price, depending on whether they meet or exceed expectations [2][12] - The consensus EPS estimate has been revised 8.84% higher in the last 30 days, indicating a more optimistic outlook from analysts [4] Earnings Surprise Prediction - Sempra has an Earnings ESP (Expected Surprise Prediction) of +0.60%, suggesting a likelihood of beating the consensus EPS estimate [12] - The company currently holds a Zacks Rank of 2 (Buy), which, when combined with a positive Earnings ESP, indicates a strong potential for an earnings beat [10][12] Historical Performance - In the last reported quarter, Sempra exceeded the expected earnings of $1.21 per share by delivering $1.44, resulting in a surprise of +19.01% [13] - Over the past four quarters, Sempra has only beaten consensus EPS estimates once [14] Industry Context - In the Zacks Utility - Gas Distribution industry, Atmos Energy (ATO) is expected to report earnings of $1.17 per share, reflecting a year-over-year increase of 8.3% [18] - Atmos Energy's revenue is projected to be $940.91 million, up 34.1% from the previous year [18] - Despite a recent downward revision of 3.4% in the consensus EPS estimate for Atmos, it has a Zacks Rank of 3 (Hold) and an Earnings ESP of 0%, making predictions about its performance less conclusive [19]

Core Viewpoint - Wall Street anticipates a year-over-year increase in earnings for Airbnb, Inc. driven by higher revenues, with a focus on how actual results compare to estimates impacting stock price [1][2]. Earnings Expectations - The upcoming earnings report is expected on August 6, with a consensus EPS estimate of $0.93, reflecting an 8.1% year-over-year increase, and revenues projected at $3.03 billion, a 10.3% increase from the previous year [3][12]. - The consensus EPS estimate has been revised 0.33% higher in the last 30 days, indicating a positive reassessment by analysts [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates a positive Earnings ESP of +3.78% for Airbnb, suggesting a likelihood of beating the consensus EPS estimate [12]. - A positive Earnings ESP is a strong predictor of an earnings beat, especially when combined with a Zacks Rank of 1, 2, or 3, which increases the predictive power of the Earnings ESP [10]. Historical Performance - In the last reported quarter, Airbnb was expected to post earnings of $0.25 per share but delivered $0.24, resulting in a -4.00% surprise [13]. - Over the last four quarters, Airbnb has only beaten consensus EPS estimates once [14]. Conclusion - While Airbnb is positioned as a compelling earnings-beat candidate, other factors may influence stock movement beyond just earnings results [15][17].

Company Overview - Dutch Bros (BROS) is anticipated to report a year-over-year decline in earnings of -5.3%, with expected earnings of $0.18 per share for the quarter ended June 2025 [3][12] - Revenue is projected to be $401.94 million, reflecting a significant increase of 23.7% compared to the same quarter last year [3] Earnings Expectations - The consensus EPS estimate has been revised down by 1.08% over the last 30 days, indicating a reassessment by analysts [4] - The Most Accurate Estimate for Dutch Bros is higher than the Zacks Consensus Estimate, resulting in a positive Earnings ESP of +1.62%, suggesting a likelihood of beating the consensus EPS estimate [12] Historical Performance - In the last reported quarter, Dutch Bros exceeded the expected earnings of $0.10 per share by delivering $0.14, resulting in a surprise of +40.00% [13] - Over the past four quarters, the company has consistently beaten consensus EPS estimates [14] Industry Context - The Zacks Retail - Restaurants industry includes other players like First Watch Restaurant Group, which is expected to post earnings of $0.07 per share, indicating a year-over-year decline of -50% [18] - First Watch's revenue is expected to be $305.97 million, up 18.3% from the previous year, but it has a negative Earnings ESP of -28.57%, making it challenging to predict an earnings beat [19][20]

Wall Street expects a year-over-year decline in earnings on lower revenues when Civitas Resources (CIVI) reports results for the quarter ended June 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates. The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on August 6. ...

Wall Street expects a year-over-year decline in earnings on lower revenues when Tango Therapeutics, Inc. (TNGX) reports results for the quarter ended June 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates. The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on Au ...

Core Viewpoint - BioCryst Pharmaceuticals (BCRX) is anticipated to report a year-over-year increase in earnings and revenues for the quarter ended June 2025, with the actual results having a significant impact on its near-term stock price [1][2]. Financial Expectations - The upcoming earnings report is expected to show quarterly earnings of $0.03 per share, reflecting a year-over-year increase of 150% [3]. - Revenues are projected to be $148.85 million, which is a 36.2% increase from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has remained unchanged over the last 30 days, indicating that analysts have not significantly reassessed their initial estimates [4]. - For BioCryst, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -66.67%, suggesting a bearish outlook from analysts [11]. Earnings Surprise History - In the last reported quarter, BioCryst was expected to post a loss of $0.07 per share but instead delivered break-even earnings, resulting in a surprise of +100.00% [12]. - Over the past four quarters, the company has beaten consensus EPS estimates two times [13]. Industry Comparison - In the Zacks Medical - Drugs industry, Indivior PLC (INDV) is expected to report earnings of $0.26 per share for the same quarter, indicating a year-over-year decline of 40.9% [17]. - Indivior's revenue is projected to be $244.27 million, down 18.3% from the previous year, but it has an Earnings ESP of +11.54%, suggesting a likelihood of beating the consensus EPS estimate [18][19].

Core Viewpoint - Wall Street anticipates a year-over-year decline in earnings for Castle Biosciences, Inc. due to lower revenues, with a focus on how actual results compare to estimates impacting stock price [1][2]. Earnings Expectations - The upcoming earnings report is expected on August 4, with a consensus estimate of a quarterly loss of $0.51 per share, reflecting a year-over-year change of -264.5% [3]. - Revenues are projected to be $73.89 million, down 15.1% from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised 26% lower in the last 30 days, indicating a reassessment by analysts [4]. - The Most Accurate Estimate matches the Zacks Consensus Estimate, resulting in an Earnings ESP of 0% [12]. Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that a positive or negative reading indicates the likely deviation of actual earnings from the consensus estimate, with a strong predictor for positive readings [9][10]. - Castle Biosciences currently holds a Zacks Rank of 4, making it challenging to predict an earnings beat [12][13]. Historical Performance - In the last reported quarter, Castle Biosciences was expected to post a loss of $0.08 per share but actually reported a loss of -$0.20, resulting in a surprise of -150.00% [14]. - Over the past four quarters, the company has beaten consensus EPS estimates three times [15]. Industry Comparison - Moderna, another player in the Zacks Medical - Biomedical and Genetics industry, is expected to report a loss of $2.99 per share, with revenues projected at $127.17 million, down 47.2% year-over-year [19][20]. - Moderna's consensus EPS estimate has been revised 1.4% lower, but it has a positive Earnings ESP of +7.22% and a Zacks Rank of 3, indicating a likelihood of beating the consensus estimate [20][21].